Cellectis
CLLS
34 hedge funds and large institutions have $51.1M invested in Cellectis in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
2,000% more call options, than puts
Call options by funds: $63K | Put options by funds: $3K
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
116% more capital invested
Capital invested by funds: $23.7M → $51.1M (+$27.4M)
21% more funds holding
Funds holding: 28 → 34 (+6)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
3.1% more ownership
Funds ownership: 11.53% → 14.63% (+3.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$13.3M |
| 2 |
BlackRock
New York
|
+$1.61M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$702K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$114K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$86.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$5.58M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$647K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$529K |
| 4 |
Millennium Management
New York
|
-$165K |
| 5 |
VF
Virtu Financial
New York
|
-$72K |
CLLS Hedge Fund Activity: Q4 2025 in Review
34 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2025, worth a combined $51.1M — up 116% from $23.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CLLS positions and 6 closed out — a net gain of 7 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was UBS AM, opening a new position worth an estimated $13.3M. The largest seller was Long Focus Capital Management, cutting an estimated $5.58M.
- 34 institutional investors held Cellectis (CLLS) as of Q4 2025, up from 28 in Q3 2025.
- Funds reported $51.1M of Cellectis stock for Q4 2025, up 116% quarter-over-quarter.
- 13 funds opened new Cellectis positions in Q4 2025 and 6 closed out, a net change of +7 holders.
- The largest Cellectis buyer in Q4 2025 was UBS AM, an estimated $13.3M added.
- The largest Cellectis seller in Q4 2025 was Long Focus Capital Management, an estimated $5.58M sold.
Based on aggregated 13F filings for Q4 2025.